Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NuVasive Inc.

This article was originally published in Start Up

Executive Summary

Nuvasive Inc. is developing a platform for minimally invasive spine surgery that combines stereotactic guidance with a neural monitoring system. With neural monitoring, surgeons can access the spine laterally, as opposed to from the back, which entails cutting through bone and splitting muscles. In this way, Nuvasive is advancing medical practice beyond merely replacing the open surgical view with endoscopic access, but otherwise leaving the fusion procedure unchanged.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT037168

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel